XML 109 R86.htm IDEA: XBRL DOCUMENT v3.25.0.1
RSA GRANTS (Details 6) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Other Liabilities [Member] | Interest Rate Lock Commitments [Member] | Not Designated as Hedging Instrument [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Interest rate lock commitments $ 2 $ 0 [1]  
Other Assets [Member] | Interest Rate Lock Commitments [Member] | Not Designated as Hedging Instrument [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Interest rate lock commitments [2] $ 77 $ 168  
Restricted stock awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 53.03    
Restricted stock awards [Member] | Employee Stock Plan [Member] | 2/17/2022 | Ratably Over 5 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted     52,100
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 84.70
Vesting terms     Ratably over 5 years from grant date
Restricted stock awards [Member] | Employee Stock Plan [Member] | 9/15/2022 | Ratably Over 5 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted     646
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 77.44
Vesting terms     Ratably over 5 years from grant date
Restricted stock awards [Member] | Employee Stock Plan [Member] | 2/16/2023 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   77,525  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 80.65  
Vesting terms   Ratably over 3 years from grant date  
Restricted stock awards [Member] | Employee Stock Plan [Member] | 2/16/2023 | Ratably Over 5 Years , on each anniversary of February 6, 2023 start date      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   12,309  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 80.65  
Vesting terms   Ratably over 5 years, on each anniversary of February 6, 2023 start date  
Restricted stock awards [Member] | Employee Stock Plan [Member] | 5/15/2023 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   1,080  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 46.21  
Vesting terms   Ratably over 3 years from grant date  
Restricted stock awards [Member] | Two Thousand Eighteen Nonemployee Director Stock Plan [Member] | 5/24/2022 | Immediately upon grant date      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted     8,099
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 80.39
Vesting terms     Immediately upon grant date
Restricted stock awards [Member] | Two Thousand Eighteen Nonemployee Director Stock Plan [Member] | 5/23/2023 | Immediately upon grant date      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   12,410  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 48.35  
Vesting terms   Immediately upon grant date  
Restricted stock awards [Member] | Two Thousand Eighteen Nonemployee Director Stock Plan [Member] | 5/21/2024 | Immediately upon grant date      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 11,340    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 52.94    
Vesting terms Immediately upon grant date    
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 5/30/2023 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   890  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 45.09  
Vesting terms   Ratably over 3 years from grant date  
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 9/15/2023 | Ratably Over 5 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   5,270  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 51.44  
Vesting terms   Ratably over 5 years from grant date  
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 9/15/2023 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   3,020  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 51.44  
Vesting terms   Ratably over 3 years from grant date  
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 12/15/2023 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   460  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 66.24  
Vesting terms   Ratably over 3 years from grant date  
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 2/22/2024 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 106,200    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 52.73    
Vesting terms Ratably over 3 years from grant date    
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 4/15/2024 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 1,650    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 48.49    
Vesting terms Ratably over 3 years from grant date    
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 8/15/2024 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 3,703    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 59.42    
Vesting terms Ratably over 3 years from grant date    
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 10/15/2024 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 1,120    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 62.32    
Vesting terms Ratably over 3 years from grant date    
Restricted stock awards [Member] | 2023 Omnibus Incentive Plan | 12/15/2024 | Ratably Over 3 Years      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 1,060    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 70.89    
Vesting terms Ratably over 3 years from grant date    
Performance Shares [Member] | Employee Stock Plan [Member] | 2/17/2022 | At The End of Period [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted     20,700
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 84.70
Vesting terms     The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2025.
Performance Shares [Member] | Employee Stock Plan [Member] | 2/16/2023 | At The End of Period [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted   32,200  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value   $ 80.65  
Vesting terms   The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2026.  
Performance Shares [Member] | 2023 Omnibus Incentive Plan | 2/22/2024 | At The End of Period [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares granted 41,200    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value $ 52.73    
Vesting terms The earlier of: the date on which it is determined if the performance goal has been achieved; or, March 31, 2027.    
[1] All liability derivatives are located in other liabilities on the balance sheet
[2] All asset derivatives are located in other assets on the balance sheet